DAVID POPLACK to Azacitidine
This is a "connection" page, showing publications DAVID POPLACK has written about Azacitidine.
Connection Strength
0.278
-
Cerebrospinal fluid pharmacokinetics and toxicology of intraventricular and intrathecal arabinosyl-5-azacytosine (fazarabine, NSC 281272) in the nonhuman primate. Invest New Drugs. 1993 May-Aug; 11(2-3):135-40.
Score: 0.106
-
Phase I trial and pharmacokinetic evaluation of fazarabine in children. Cancer Res. 1989 Sep 15; 49(18):5213-6.
Score: 0.083
-
Preclinical pharmacology of arabinosyl-5-azacytidine in nonhuman primates. Cancer Res. 1988 Aug 01; 48(15):4294-8.
Score: 0.077
-
Phase II study of 5-azacytidine in sarcomas of bone. Am J Clin Oncol. 1982 Aug; 5(4):411-5.
Score: 0.013